Drug Trial Radar · NCT06909214
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
35
Planned (sponsor's estimate)
Start
Apr 17, 2025
Primary completion
Jul 8, 2026
Study completion Dec 2027
Sponsor
- Lead sponsor
- argenxargenx (ARGX)
- Sponsor type
- Industry
- First posted
- Apr 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to measure how well adults with new-onset gMG (which means they've had generalized disease signs and/or symptoms for less than 1 year) respond to treatment with efgartigimod PH20 SC. The study consists of a treatment period of 103 weeks (51 weeks in stage 1, 52 weeks in stage 2). The study duration for each participant will be approximately 107 weeks.
Conditions
- New Onset Generalized Myasthenia Gravis (gMG)
Interventions
Efgartigimod PH20 SCBiological
Subcutaneous injection of efgartigimod PH20 SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants who reach MSE of MG at any time within the first 16 weeks of stage 1 treatment with efgartigimod PH20 SCTime frame: up to 16 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
University of California, San Diego - Altman Clinical and Translational Research Institute (ACTRI)
La Jolla, California · Recruiting
Samir Macwan, M.D., Inc. (S corporation)
Rancho Mirage, California · Recruiting
EZR Research
Boca Raton, Florida · Recruiting
University of Florida Jacksonville
Jacksonville, Florida · Recruiting
Visionary Investigators Network
Miami, Florida · Recruiting
University of California Irvine
Orange, Florida · Recruiting
Medsol Clinical Research Center Inc
Port Charlotte, Florida · Recruiting
Baycare Medical Group
St. Petersburg, Florida · Recruiting
Emory Brain Health Center
Atlanta, Georgia · Recruiting
The Queen's Medical Center - West Oahu
Honolulu, Hawaii · Recruiting
Hawaii Pacific Neuroscience
Honolulu, Hawaii · Recruiting
HSHS Medical Group
O'Fallon, Illinois · Recruiting
UMass Memorial Medical Center
Worcester, Massachusetts · Recruiting
Henry Ford Health System
Detroit, Michigan · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Erlanger Neuroscience Institute
Chattanooga, Tennessee · Recruiting
Central Texas Neurology Consultants - Elligo
Round Rock, Texas · Recruiting
Center for Neurological Disorders - Greenfield
Greenfield, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.